SONGWON Demonstrates Industry Commitment & Unveils New Solutions at K2019
Retardants

SONGWON Demonstrates Industry Commitment & Unveils New Solutions at K2019

SONGWON unveils new family of flame-retardant synergists SONGWON showcases broad portfolio of high-performance solutions SONGWON confirms its commitment to advancement in the plastics industry Ulsan, South Korea – October 16, 2019 – Songwon Industrial Co., Ltd., the 2nd largest manufacturer of polymer stabilizers in the world and a key global specialty chemicals player will be showcasing its...

Read More »
Pharmaceuticals

Lilly Presents Positive Results for Taltz® (ixekizumab) in Pediatric Patients with Moderate to Severe Plaque Psoriasis at the 28th Annual European Academy of Dermatology and Venereology (EADV) Congress

Taltz is the first and only IL-17A inhibitor with published clinical trial results in pediatric patients with moderate to severe plaque psoriasis Indianapolis, Oct. 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Taltz met co-primary endpoints as well as all major secondary endpoints in a Phase 3 study in pediatric patients with moderate to severe plaque...

Read More »
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
Therapy Equipment

Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy

PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a Varian ProBeam® proton therapy gantry treatment...

Read More »

All Topics